Metraipolis › archive › dc_e6b4bb1adea3

From Single Agents to Synergy: Redefining Therapeutic Strategies in MASLD — Europe PMC PMID:42794795

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42794795
DOI
10.3390/ijms27188368
License (as archived)
solo-consultazione
Archived
2026-10-08T01:46:28.283Z
SHA-256 of the archived text
f89e83587b3ce31326a08d67fe5bd82355358fb2b6316715cbbd6d704bc8bb42
Stable URL of this page
https://metraipolis.com/documento/dc_e6b4bb1adea3

How to cite

From Single Agents to Synergy: Redefining Therapeutic Strategies in MASLD — Europe PMC PMID:42794795 — Europe PMC (en), https://europepmc.org/article/MED/42794795 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e6b4bb1adea3 (Metraipolis archive dc_e6b4bb1adea3, sha256 f89e83587b3ce31326a08d67fe5bd82355358fb2b6316715cbbd6d704bc8bb42)
BibTeX
@misc{dce6b4bb1adea3,
  title = {From Single Agents to Synergy: Redefining Therapeutic Strategies in MASLD — Europe PMC PMID:42794795},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42794795},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e6b4bb1adea3; sha256 f89e83587b3ce31326a08d67fe5bd82355358fb2b6316715cbbd6d704bc8bb42},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42794795. Agents can read the archived copy with the MCP tool read_document.